英文别名: |
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol;Cangrelor Intermediate;Cangrelor Intermediates;N6-(2-Methylthioethyl)-2-(3,3,3-trifluoropropylthio)adenosine;N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]adenosine;Adenosine, N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]- (9CI);(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl);((3aR,4R,6R,6aR)-6-(6-amino-2-((3,3,3-trifluoropropyl)thio)-9H- purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol;(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol;(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol Cangrelor Intermediate;(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2- ((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol N6-(2-Methylthioethyl)-2-(3,3,3-trifluoropropylthio)adenosine |
中文别名: |
4-氨基烟酸甲酯;N6-(2-甲硫基乙基) -2-(3,3,3-三氟丙硫基)腺苷;坎格雷洛中间体;2R,3S,4R,5R)- 2 -(羟甲基)- 5 -(6 -((2 -(甲硫基)乙基)氨基)-2-((3,3,3-三甲基三氟丙基硫代)-9H-嘌呤-9-基)四氢呋喃-3,4-二醇;坎格雷诺C3中间体;N6-(2-甲硫基乙基)-2-(3,3,3-三氟丙硫基)腺苷;N6-(2-甲硫基乙基)-2-(3,3,3-三氟丙硫基)腺苷;N6-(2-甲硫基乙基)-2-(3,3,3-三氟丙硫基)腺苷;N-[2-(甲硫基)乙基]-2-[(3,3,3-三氟丙基)硫基]腺苷;坎格雷诺中间体;坎格瑞洛中间体2;坎格雷洛中间体2;坎格雷洛中间体3;坎格雷洛中间体 50G;坎格雷洛CANGRELOR中间体;N6-[2-(甲硫基)乙基]-2-[(3,3,3-三氟丙基)硫基]腺苷 |